Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T cell attack.
Alarmins
/ genetics
Animals
Antibodies, Neutralizing
/ pharmacology
Cancer Vaccines
/ administration & dosage
Female
Gene Expression
Genetic Engineering
/ methods
Genetic Vectors
/ classification
Guinea Pigs
Immunization, Secondary
Immunotherapy
/ methods
Lymphocytic choriomeningitis virus
/ classification
Mastocytoma
/ genetics
Mice
Mice, Inbred C57BL
Phylogeny
Pichinde virus
/ classification
Self Tolerance
Survival Analysis
T-Lymphocytes, Cytotoxic
/ immunology
Vaccination
/ methods
CD8 T cells
Pichinde virus
anti-vector immunity
arenavirus
lymphocytic choriomeningitis virus
pre-existing immunity
therapeutic tumor vaccine
tumor control
viral genealogy
Journal
Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894
Informations de publication
Date de publication:
16 03 2021
16 03 2021
Historique:
received:
15
09
2020
revised:
16
12
2020
accepted:
04
02
2021
entrez:
25
3
2021
pubmed:
26
3
2021
medline:
26
3
2021
Statut:
epublish
Résumé
Therapeutic vaccination regimens inducing clinically effective tumor-specific CD8
Identifiants
pubmed: 33763654
doi: 10.1016/j.xcrm.2021.100209
pii: S2666-3791(21)00020-3
pmc: PMC7974551
doi:
Substances chimiques
Alarmins
0
Antibodies, Neutralizing
0
Cancer Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
100209Informations de copyright
© 2021 The Author(s).
Déclaration de conflit d'intérêts
S.S., J.R., U.B., and K.K.O. are employees and stock option holders of Hookipa Pharma, Inc. D.D.P. is a founder, consultant, shareholder, and stock option holder of Hookipa Pharma, Inc. W.V.B., S.M.K., S.S., S.D., U.B., D.D.P., D.M., and K.K.O. are listed as inventors on patents describing artARENA vector technology. W.V.B. and D.D.P. are married.
Références
Nat Med. 2010 Mar;16(3):339-45
pubmed: 20139992
Nat Commun. 2015 Sep 25;6:8306
pubmed: 26404698
Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7895-900
pubmed: 12808132
Nat Immunol. 2001 Nov;2(11):1032-9
pubmed: 11600886
J Med Virol. 2003 Jun;70(2):273-5
pubmed: 12696116
Nat Commun. 2017 May 26;8:15327
pubmed: 28548102
J Virol. 2015 Dec 16;90(5):2551-60
pubmed: 26676795
J Virol. 1999 Jun;73(6):4748-54
pubmed: 10233935
Vet Q. 1999 Apr;21(2):50-4
pubmed: 10321013
PLoS Pathog. 2015 Nov 20;11(11):e1005276
pubmed: 26587982
Int J Cancer. 1997 Jan 27;70(3):349-56
pubmed: 9033639
Sci Transl Med. 2012 Jan 4;4(115):115ra1
pubmed: 22218690
J Natl Cancer Inst. 1995 Jul 5;87(13):982-90
pubmed: 7629885
Nat Med. 2004 Sep;10(9):909-15
pubmed: 15340416
Curr Opin Virol. 2017 Apr;23:75-81
pubmed: 28453967
Methods Mol Biol. 2007;409:75-93
pubmed: 18449993
Annu Rev Immunol. 2019 Apr 26;37:457-495
pubmed: 30676822
Immunity. 2013 Jun 27;38(6):1250-60
pubmed: 23746652
N Engl J Med. 2003 Jan 16;348(3):203-13
pubmed: 12529460
Science. 2006 Sep 29;313(5795):1960-4
pubmed: 17008531
Brain. 2010 Apr;133(Pt 4):1054-66
pubmed: 20354003
Lancet. 2008 Nov 29;372(9653):1894-1905
pubmed: 19012957
Transfusion. 2007 Jan;47(1):172-3
pubmed: 17207247
PLoS Comput Biol. 2019 Apr 8;15(4):e1006650
pubmed: 30958812
J Immunol. 1999 Dec 15;163(12):6462-7
pubmed: 10586037
Arch Virol. 1989;106(3-4):201-12
pubmed: 2476109
J Virol. 2012 Aug;86(15):7760-70
pubmed: 22593152
Immunity. 2007 Aug;27(2):281-95
pubmed: 17723218
J Infect Dis. 2020 Apr 21;:
pubmed: 32313928
Cancer J. 2011 Sep-Oct;17(5):359-71
pubmed: 21952287
Nature. 2017 Jul 13;547(7662):165-167
pubmed: 28678783
Nature. 2016 Dec 8;540(7632):284-287
pubmed: 27841870
J Exp Med. 2006 Feb 20;203(2):413-24
pubmed: 16461338
PLoS Pathog. 2006 Jun;2(6):e51
pubmed: 16751848
Arch Virol. 2008;153(7):1241-50
pubmed: 18506572
Nat Med. 2014 Oct;20(10):1126-9
pubmed: 25194571
J Immunol. 2003 Nov 15;171(10):5415-22
pubmed: 14607945
J Immunother. 2017 Oct;40(8):302-306
pubmed: 28891906
Nature. 2014 Nov 27;515(7528):568-71
pubmed: 25428505
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3473-8
pubmed: 19208813
Nat Rev Immunol. 2014 Nov;14(11):768-74
pubmed: 25257362
J Clin Oncol. 2010 Mar 1;28(7):1099-105
pubmed: 20100959
J Clin Invest. 2012 Jan;122(1):359-67
pubmed: 22201684
Sci Transl Med. 2014 Mar 5;6(226):226ra32
pubmed: 24598590
Proc Natl Acad Sci U S A. 2015 Mar 31;112(13):4056-61
pubmed: 25829541
Immunity. 2016 Aug 16;45(2):415-27
pubmed: 27533016
J Exp Med. 2000 Mar 20;191(6):1069-76
pubmed: 10727469
J Virol Methods. 1991 Jun;33(1-2):191-8
pubmed: 1939506
Science. 1999 Feb 5;283(5403):857-60
pubmed: 9933172
J Virol. 2008 Jan;82(1):546-54
pubmed: 17942545
Immunity. 2015 May 19;42(5):929-41
pubmed: 25992863
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4663-8
pubmed: 16537369
Nature. 1972 Aug 11;238(5363):335-7
pubmed: 4561841
J Exp Med. 1999 Mar 15;189(6):991-8
pubmed: 10075982
Nature. 2006 May 11;441(7090):239-43
pubmed: 16625206
J Clin Oncol. 2019 May 1;37(13):1051-1061
pubmed: 30817251
Sci Transl Med. 2012 Jan 4;4(115):115ra2
pubmed: 22218691
Lancet Oncol. 2016 Jun;17(6):822-835
pubmed: 27132212
J Immunol. 2006 Apr 1;176(7):4235-43
pubmed: 16547260
Infect Immun. 1974 May;9(5):821-3
pubmed: 4856825
N Engl J Med. 2019 Nov 14;381(20):1897-1908
pubmed: 31722150
J Immunol. 2005 Dec 15;175(12):8431-7
pubmed: 16339586
N Engl J Med. 2005 Dec 22;353(25):2654-66
pubmed: 16371631
J Immunol. 2001 Nov 1;167(9):4838-43
pubmed: 11673487
Curr Top Microbiol Immunol. 2002;263:1-5
pubmed: 11987811
J Immunol Methods. 2012 Aug 31;382(1-2):224-8
pubmed: 22698786
Int Immunol. 1993 Jun;5(6):647-56
pubmed: 8347558
Nat Immunol. 2013 Jun;14(6):603-10
pubmed: 23644506
J Immunol. 2012 Jan 1;188(1):111-21
pubmed: 22140254
Blood. 2013 Mar 28;121(13):2432-9
pubmed: 23325836
Nature. 1991 May 23;351(6324):290-6
pubmed: 1709722
N Engl J Med. 2019 Dec 26;381(26):2553-2560
pubmed: 31881142
Science. 2012 Feb 24;335(6071):984-9
pubmed: 22323740
Science. 2015 Apr 3;348(6230):74-80
pubmed: 25838376
Virology. 2006 Jul 5;350(2):370-80
pubmed: 16476461
J Child Neurol. 2015 Apr;30(5):644-7
pubmed: 24736119
Vaccine. 2018 Apr 12;36(16):2181-2192
pubmed: 29544689
NPJ Vaccines. 2019 Feb 8;4:7
pubmed: 30774998
Vaccine. 1993;11(11):1154-8
pubmed: 8249436
J Transl Med. 2020 Jan 30;18(1):39
pubmed: 32000810
Immunity. 2016 Dec 20;45(6):1270-1284
pubmed: 27939671
J Exp Med. 2000 Mar 6;191(5):795-804
pubmed: 10704461
Swiss Med Wkly. 2017 Aug 14;147:w14465
pubmed: 28804866
Nat Med. 2009 Aug;15(8):873-5
pubmed: 19620961
N Engl J Med. 2010 Jul 29;363(5):411-22
pubmed: 20818862
Lancet Oncol. 2014 Jan;15(1):59-68
pubmed: 24331154
Sci Transl Med. 2016 Apr 13;8(334):334ps9
pubmed: 27075624
Nat Immunol. 2013 Oct;14(10):1014-22
pubmed: 24048123
J Med Virol. 1992 Sep;38(1):27-31
pubmed: 1402829
Vaccine. 2004 Jan 2;22(3-4):520-7
pubmed: 14670335
Vaccine. 2017 Jan 3;35(1):1-9
pubmed: 27899229
J Infect Dis. 1998 Feb;177(2):277-83
pubmed: 9466512
Nat Immunol. 2000 Nov;1(5):433-40
pubmed: 11062504
Trends Immunol. 2016 May;37(5):321-333
pubmed: 27055914
J Exp Med. 2000 Oct 16;192(8):1105-13
pubmed: 11034600
Clin Vaccine Immunol. 2009 Aug;16(8):1132-8
pubmed: 19553554
Cancer Res. 1996 Jan 1;56(1):21-6
pubmed: 8548765
J Clin Invest. 2010 Sep;120(9):3234-41
pubmed: 20679728